Management of Metastatic Liver Tumors, An Issue of Hematology/Oncology Clinics of North America - D'Angelica, Michael; (ed.) - Prospero Internet Bookshop

Management of Metastatic Liver Tumors, An Issue of Hematology/Oncology Clinics of North America
 
Product details:

ISBN13:9780443346798
ISBN10:0443346798
Binding:Hardback
No. of pages: pages
Size:228x152 mm
Weight:450 g
Language:English
695
Category:

Management of Metastatic Liver Tumors, An Issue of Hematology/Oncology Clinics of North America

 
Publisher: Elsevier
Date of Publication:
 
Normal price:

Publisher's listprice:
EUR 101.99
Estimated price in HUF:
44 335 HUF (42 223 HUF + 5% VAT)
Why estimated?
 
Your price:

35 467 (33 778 HUF + 5% VAT )
discount is: 20% (approx 8 867 HUF off)
Discount is valid until: 31 December 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

 
  Piece(s)

 
Long description:
In this issue of Hematology/Oncology Clinics, guest editor Dr. Michael D’Angelica brings his considerable expertise to the topic of Management of Metastatic Liver Tumors. Top experts cover key topics such as surgical management of colorectal cancer liver metastases, breast cancer liver metastasis, and neuroendocrine tumor liver metastases; surgical management of sarcoma metastatic to liver; surgical management of gynecologic cancers; and many more.
  • Contains 13 relevant, practice-oriented topics including liver directed locoregional therapies; intraarterial chemotherapy for liver metastases; external beam radiation therapy for liver metastases; hepatic perfusion for diffuse metastatic cancer to the liver: open and percutaneous techniques; and more.
  • Provides in-depth clinical reviews on management of metastatic liver tumors, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.